{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:58:27Z","timestamp":1792979907173,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011596","name":"Generalitat of Valencia Ministry of Education Culture Universities and Employment","doi-asserted-by":"publisher","award":["CIPROM\/2021\/044"],"award-info":[{"award-number":["CIPROM\/2021\/044"]}],"id":[{"id":"10.13039\/501100011596","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2022\\u2013137678OB-I00"],"award-info":[{"award-number":["PID2022\\u2013137678OB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2021\\u2013127945OB-I00"],"award-info":[{"award-number":["PID2021\\u2013127945OB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["MCIN\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["MCIN\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["InnovationMCIN\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["InnovationMCIN\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.biopha.2025.118831","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T05:10:32Z","timestamp":1764306632000},"page":"118831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Differential adipose tissue remodeling and metabolic effects of dolutegravir and bictegravir: implications for HIV therapy"],"prefix":"10.1016","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2007-8716","authenticated-orcid":false,"given":"Laura","family":"Gisbert-Ferr\u00e1ndiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4218-7363","authenticated-orcid":false,"given":"Patricia","family":"Garc\u00eda-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8205-021X","authenticated-orcid":false,"given":"Juan V.","family":"Esplugues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2301-9746","authenticated-orcid":false,"given":"\u00c1ngeles","family":"\u00c1lvarez-Ribelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7870-1470","authenticated-orcid":false,"given":"Ana","family":"Blas-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118831_bib1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/infdis\/jiz118","article-title":"Obesity and fat metabolism in human immunodeficiency virus-infected individuals: immunopathogenic mechanisms and clinical implications","volume":"220","author":"Godfrey","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biopha.2025.118831_bib2","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1093\/cid\/civ192","article-title":"Weight change after antiretroviral therapy and mortality","volume":"60","author":"Yuh","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biopha.2025.118831_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010106","article-title":"Infectious disease clinical research program hiv working group, increasing rates of obesity among HIV-infected persons during the HIV epidemic","volume":"5","author":"Crum-Cianflone","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118831_bib4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1089\/aid.2015.0147","article-title":"North American AIDS cohort collaboration on research and design (NA-ACCORD), rising obesity prevalence and weight gain among adults starting antiretroviral therapy in the United States and Canada","volume":"32","author":"Koethe","year":"2016","journal-title":"AIDS Res Hum. Retrovir."},{"key":"10.1016\/j.biopha.2025.118831_bib5","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.3390\/v15122432","article-title":"Impact of combination antiretroviral treatment on liver metabolic health in HIV-infected persons","volume":"15","author":"Bia\u0142y","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.biopha.2025.118831_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101116","article-title":"Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART)","volume":"40","author":"Bischoff","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.biopha.2025.118831_bib7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1212\/WNL.0b013e3182478d64","article-title":"CHARTER Group, Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder","volume":"78","author":"McCutchan","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2025.118831_bib8","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1097\/QAD.0000000000001496","article-title":"HIV-NAT 006 team, New-onset diabetes in HIV-treated adults: predictors, long-term renal and cardiovascular outcomes","volume":"31","author":"Putcharoen","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.biopha.2025.118831_bib9","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/hiv.13644","article-title":"Improvement in insulin sensitivity after switching from an integrase inhibitor-based regimen to doravirine\/tenofovir disoproxil fumarate\/lamivudine in people with significant weight gain","volume":"25","author":"Calza","year":"2024","journal-title":"HIV Med"},{"key":"10.1016\/j.biopha.2025.118831_bib10","article-title":"Weight changes with integrase strand transfer inhibitor therapy in the management of HIV infection: a systematic review","author":"Hester","year":"2022","journal-title":"Ann. Pharm."},{"key":"10.1016\/j.biopha.2025.118831_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/09564624231196605","article-title":"Weight gain and metabolic disturbances in people living with HIV who start antiretroviral therapy with, or switch to, bictegravir\/emtricitabine\/tenofovir alafenamide after 48 weeks of treatment: a real-world prospective study","volume":"35","author":"Mata Mar\u00edn","year":"2024","journal-title":"Int J. STD AIDS"},{"key":"10.1016\/j.biopha.2025.118831_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab077","article-title":"Bictegravir-based antiretroviral therapy-associated accelerated hyperglycemia and diabetes mellitus","volume":"8","author":"Nolan","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.biopha.2025.118831_bib13","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/cid\/ciz999","article-title":"Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials","volume":"71","author":"Sax","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biopha.2025.118831_bib14","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/cid\/ciae191","article-title":"Antiretrovirals and weight change: weighing the evidence","volume":"79","author":"Wohl","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biopha.2025.118831_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/QCO.0000000000000616","article-title":"Weight gain and integrase inhibitors","volume":"33","author":"Eckard","year":"2020","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.biopha.2025.118831_bib16","author":"Hoffmann","year":"2023","journal-title":"HIV 2023\/2024 Hambg. Ger."},{"key":"10.1016\/j.biopha.2025.118831_bib17","unstructured":"World Health Organization, Update of recommendations on first- and second-line antiretroviral regimens, 2019. \u3008https:\/\/www.who.int\/hiv\/pub\/arv\/arv-update-2019-policy\/en\/\u3009."},{"key":"10.1016\/j.biopha.2025.118831_bib18","doi-asserted-by":"crossref","first-page":"6666","DOI":"10.1038\/s41598-020-63710-4","article-title":"WAT-on-a-chip integrating human mature white adipocytes for mechanistic research and pharmaceutical applications","volume":"10","author":"Rogal","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118831_bib19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41580-018-0093-z","article-title":"Adipogenesis and metabolic health","volume":"20","author":"Ghaben","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118831_bib20","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.3390\/nu15183968","article-title":"Adipose tissue dynamics: cellular and lipid turnover in health and disease","volume":"15","author":"Palacios-Marin","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2025.118831_bib21","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/jac\/dky551","article-title":"Progressive increases in fat mass occur in adults living with HIV on antiretroviral therapy, but patterns differ by sex and anatomic depot","volume":"74","author":"Debroy","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.biopha.2025.118831_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2055-6640(20)30277-6","article-title":"Are new antiretroviral treatments increasing the risks of clinical obesity?","volume":"5","author":"Hill","year":"2019","journal-title":"J. Virus Erad."},{"key":"10.1016\/j.biopha.2025.118831_bib23","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/cid\/ciw017","article-title":"Body composition changes after initiation of raltegravir or protease inhibitors: ACTG A5260s","volume":"62","author":"McComsey","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biopha.2025.118831_bib24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.antiviral.2018.04.002","article-title":"Adipocytes impair efficacy of antiretroviral therapy","volume":"154","author":"Couturier","year":"2018","journal-title":"Antivir. Res"},{"key":"10.1016\/j.biopha.2025.118831_bib25","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nature06902","article-title":"Dynamics of fat cell turnover in humans","volume":"453","author":"Spalding","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118831_bib26","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nature05483","article-title":"Adipocytes as regulators of energy balance and glucose homeostasis","volume":"444","author":"Rosen","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118831_bib27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/QAI.0b013e31825c3a68","article-title":"Adipogenic\/lipid, inflammatory, and mitochondrial parameters in subcutaneous adipose tissue of untreated HIV-1-infected long-term nonprogressors: significant alterations despite low viral burden","volume":"61","author":"Vidal","year":"2012","journal-title":"J. Acquir Immune Defic. Syndr."},{"key":"10.1016\/j.biopha.2025.118831_bib28","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1177\/135965350601100610","article-title":"HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV- 1\/HAART-associated lipodystrophy","volume":"11","author":"Giralt","year":"2006","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.biopha.2025.118831_bib29","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/toxsci\/kfu092","article-title":"Toxicogenomics in the 3T3-L1 cell line, a new approach for screening of obesogenic compounds","volume":"140","author":"Pereira-Fernandes","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.biopha.2025.118831_bib30","doi-asserted-by":"crossref","DOI":"10.1080\/21623945.2023.2235081","article-title":"Housekeeping gene expression variability in differentiating and non-differentiating 3T3-L1 cells","volume":"12","author":"Cahyadi","year":"2023","journal-title":"Adipocyte"},{"key":"10.1016\/j.biopha.2025.118831_bib31","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2025.118831_bib32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40268-016-0148-6","article-title":"An updated overview on therapeutic drug monitoring of recent antiepileptic drugs","volume":"16","author":"Jacob","year":"2016","journal-title":"Drugs R. D."},{"key":"10.1016\/j.biopha.2025.118831_bib33","doi-asserted-by":"crossref","first-page":"e2234","DOI":"10.1093\/cid\/ciaa1403","article-title":"Risk of incident diabetes mellitus, weight gain, and their relationships with integrase inhibitor-based initial antiretroviral therapy among persons with human immunodeficiency virus in the United States and Canada","volume":"73","author":"Rebeiro","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biopha.2025.118831_bib34","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1097\/QAD.0000000000002245","article-title":"Dolutegravir monotherapy and body weight gain in antiretroviral na\u00efve patients","volume":"33","author":"Rizzardo","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.biopha.2025.118831_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120948","article-title":"Differential effects of dolutegravir, bictegravir and raltegravir in adipokines and inflammation markers on human adipocytes","volume":"308","author":"Domingo","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2025.118831_bib36","doi-asserted-by":"crossref","first-page":"e549","DOI":"10.1093\/cid\/ciaa259","article-title":"The integrase inhibitors dolutegravir and raltegravir exert proadipogenic and profibrotic effects and induce insulin resistance in human\/simian adipose tissue and human adipocytes","volume":"71","author":"Gorwood","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biopha.2025.118831_bib37","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.3390\/cells11111841","article-title":"Inhibition of adipose tissue beiging by HIV integrase inhibitors, dolutegravir and bictegravir, is associated with adipocyte hypertrophy, hypoxia, elevated fibrosis, and insulin resistance in simian adipose tissue and human adipocytes","volume":"11","author":"Ngono Ayissi","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2025.118831_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.116010","article-title":"Divergent effects of the antiretroviral drugs, dolutegravir, tenofovir alafenamide, and tenofovir disoproxil fumarate, on human adipocyte function","volume":"220","author":"Quesada-L\u00f3pez","year":"2024","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2025.118831_bib39","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/infdis\/jiac175","article-title":"Dolutegravir suppresses thermogenesis via disrupting uncoupling protein 1 expression and mitochondrial function in brown\/beige adipocytes in preclinical models","volume":"226","author":"Jung","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biopha.2025.118831_bib40","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/QAD.0000000000003455","article-title":"Adipocyte differentiation of 3T3-L1 cells under tenofovir alafenamide, tenofovir disoproxil fumarate, and integrase strand transfer inhibitors selective challenge: an in-vitro model","volume":"37","author":"Perna","year":"2023","journal-title":"AIDS"},{"key":"10.1016\/j.biopha.2025.118831_bib41","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11904-024-00708-x","article-title":"Metabolic complications associated with use of integrase strand transfer inhibitors (InSTI) for the treatment of HIV-1 infection: focus on weight changes, lipids, glucose and bone metabolism","volume":"21","author":"Savinelli","year":"2024","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.biopha.2025.118831_bib42","doi-asserted-by":"crossref","DOI":"10.1177\/20503121241260613","article-title":"A review of dolutegravir-associated weight gain and secondary metabolic comorbidities","volume":"12","author":"Jemal","year":"2024","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.biopha.2025.118831_bib43","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/nm.3324","article-title":"Tracking adipogenesis during white adipose tissue development, expansion and regeneration","volume":"19","author":"Wang","year":"2013","journal-title":"Nat. Med"},{"key":"10.1016\/j.biopha.2025.118831_bib44","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2337\/db09-0942","article-title":"Adipocyte turnover: relevance to human adipose tissue morphology","volume":"59","author":"Arner","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2025.118831_bib45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1101\/gad.948702","article-title":"C\/EBPalpha induces adipogenesis through PPARgamma: a unified pathway","volume":"16","author":"Rosen","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.biopha.2025.118831_bib46","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1097-2765(00)80211-7","article-title":"PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro","volume":"4","author":"Rosen","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biopha.2025.118831_bib47","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0092-8674(94)90006-X","article-title":"Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor","volume":"79","author":"Tontonoz","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.118831_bib48","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.tem.2008.11.005","article-title":"New developments in adipogenesis","volume":"20","author":"Lefterova","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2025.118831_bib49","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3390\/ijms17010124","article-title":"Molecular regulation of adipogenesis and potential anti-adipogenic bioactive molecules","volume":"17","author":"Moseti","year":"2016","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118831_bib50","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/jac\/dky507","article-title":"Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patients","volume":"74","author":"Calza","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.biopha.2025.118831_bib51","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1093\/jac\/dkab158","article-title":"NEAT022 Study Group, Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV","volume":"76","author":"Gonz\u00e1lez-Cord\u00f3n","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.biopha.2025.118831_bib52","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1093\/jac\/dkad247","article-title":"NEAT 022 Study Group, Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir","volume":"78","author":"Gonz\u00e1lez-Cord\u00f3n","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.biopha.2025.118831_bib53","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/s41467-018-03196-x","article-title":"De novo adipocyte differentiation from Pdgfr\u03b2+ preadipocytes protects against pathologic visceral adipose expansion in obesity","volume":"9","author":"Shao","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118831_bib54","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.2337\/db08-1770","article-title":"Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation","volume":"58","author":"Isakson","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2025.118831_bib55","doi-asserted-by":"crossref","first-page":"R284","DOI":"10.1152\/ajpregu.00257.2017","article-title":"Adipose cell size: importance in health and disease","volume":"315","author":"Stenkula","year":"2018","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.biopha.2025.118831_bib56","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3390\/ijms20092358","article-title":"Adipose tissue dysfunction as determinant of obesity-associated metabolic complications","volume":"20","author":"Longo","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118831_bib57","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1172\/JCI105705","article-title":"The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity","volume":"47","author":"Salans","year":"1968","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.biopha.2025.118831_bib58","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1172\/JCI129191","article-title":"Contribution of adipogenesis to healthy adipose tissue expansion in obesity","volume":"129","author":"Vishvanath","year":"2019","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.biopha.2025.118831_bib59","doi-asserted-by":"crossref","first-page":"C375","DOI":"10.1152\/ajpcell.00379.2020","article-title":"Adipose tissue inflammation and metabolic dysfunction in obesity","volume":"320","author":"Kawai","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.biopha.2025.118831_bib60","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fendo.2016.00030","article-title":"Adipose tissue remodeling: its role in energy metabolism and metabolic disorders","volume":"7","author":"Choe","year":"2016","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.biopha.2025.118831_bib61","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00125-008-1223-5","article-title":"Basal lipolysis, not the degree of insulin resistance, differentiates large from small isolated adipocytes in high-fat fed mice","volume":"52","author":"Wueest","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2025.118831_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.106020","article-title":"Bictegravir alters glucose tolerance in vivo and causes hepatic mitochondrial dysfunction","volume":"231","author":"Garc\u00eda-Mart\u00ednez","year":"2024","journal-title":"Antivir. Res"},{"key":"10.1016\/j.biopha.2025.118831_bib63","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0140-6736(02)08094-7","article-title":"Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance","volume":"359","author":"Bastard","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2025.118831_bib64","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.cmet.2013.06.016","article-title":"Fibrosis and adipose tissue dysfunction","volume":"18","author":"Sun","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2025.118831_bib65","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.3390\/ijms21176030","article-title":"Adipose tissue fibrosis: mechanisms, models, and importance","volume":"21","author":"DeBari","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118831_bib66","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1083\/jcb.149.3.667","article-title":"Roles of autocrine TGF-beta receptor and Smad signaling in adipocyte differentiation","volume":"149","author":"Choy","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118831_bib67","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13287-020-1552-y","article-title":"TGF-\u03b2\/SMAD signaling regulation of mesenchymal stem cells in adipocyte commitment","volume":"11","author":"Li","year":"2020","journal-title":"Stem Cell Res Ther."},{"key":"10.1016\/j.biopha.2025.118831_bib68","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1538\/expanim.58.141","article-title":"Genetic differences among C57BL\/6 substrains","volume":"58","author":"Mekada","year":"2009","journal-title":"Exp. Anim."},{"key":"10.1016\/j.biopha.2025.118831_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.1003118","article-title":"Of mice and men: pinpointing species differences in adipose tissue biology","volume":"10","author":"B\u00f6rgeson","year":"2022","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2025.118831_bib70","first-page":"1077","article-title":"Circadian dysfunction in adipose tissue: chronotherapy in metabolic diseases","volume":"12","author":"Civelek","year":"2023","journal-title":"Biol. (Basel)"},{"key":"10.1016\/j.biopha.2025.118831_bib71","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/obr.12621","article-title":"Meta-analysis on shift work and risks of specific obesity types","volume":"19","author":"Sun","year":"2018","journal-title":"Obes. Rev."},{"key":"10.1016\/j.biopha.2025.118831_bib72","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41574-018-0122-1","article-title":"Circadian clocks and insulin resistance","volume":"15","author":"Stenvers","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.biopha.2025.118831_bib73","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1152\/physrev.00021.2023","article-title":"Glucocorticoids, their uses, sexual dimorphisms, and diseases: new concepts, mechanisms, and discoveries","volume":"104","author":"Martinez","year":"2024","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2025.118831_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050435","article-title":"Glucocorticoids affect 24h clock genes expression in human adipose tissue explant cultures","volume":"7","author":"G\u00f3mez-Abell\u00e1n","year":"2012","journal-title":"PLoS One"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222501025X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222501025X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:44:05Z","timestamp":1778633045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222501025X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":74,"alternative-id":["S075333222501025X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118831","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential adipose tissue remodeling and metabolic effects of dolutegravir and bictegravir: implications for HIV therapy","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118831","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118831"}}